Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Revive Therapeutics Ltd
C.RVV
Alternate Symbol(s):
RVVTF
Healthcare
Biotechnology
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for infectious diseases and medical countermeasures. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro...
diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. The Company is also advancing the development of Psilocybin and molecular hydrogen therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:RVV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 22, 2022 9:20am
New Press Release - Revive Therapeutics Announces FDA Recommendation for Type C Meeting to Discuss Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19
TORONTO, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced today that the U.S...
read article.
(27)
•••
cool888
X
Post by
cool888
on Nov 21, 2022 7:19am
Reddit - Revive is sitting on a "gold mine" with Bucillamine
#Bucillamine https://www.reddit.com/r/RVVTF/comments/z0o2kh/credentialed_immunologist_thinks_revive_is/
(19)
•••
newonthestreet
X
Comment by
newonthestreet
on Nov 20, 2022 12:51pm
RE:SOON ????
This week, next week. Thats all i read for the last two years. Its always next week. I lost hope.
(145)
•••
CrazyProphet
X
Post by
CrazyProphet
on Nov 20, 2022 8:32am
SOON ????
This week works fine ! Lets watch this long long journey end in a major reevaluation of the stock price for it shall be long overdue and sweeter than sweet for all the investors !!!
(22)
•••
hk1966
X
Comment by
hk1966
on Nov 17, 2022 8:12pm
RE:RE:Fda loves to waste Canucks time
Rout coming to this soon bunka bunka bunka. See you down at a dime slick
(27)
•••
cool888
X
Post by
cool888
on Nov 10, 2022 6:36am
U.S.FDA panel votes against Veru's COVID-19 pill
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-panel-votes-against-verus-covid-19-pill-2022-11-09/
(22)
•••
hk1966
X
Comment by
hk1966
on Nov 07, 2022 10:00am
RE:RE:Fda loves to waste Canucks time
Ok Coolio. Drop another album...oops sorry guess you can't since you're dead dude
(19)
•••
newonthestreet
X
Post by
newonthestreet
on Nov 06, 2022 11:39am
Everyone
Sayin RVV more than a one trick pony. I just wanna see one trick already!!
(2)
•••
CoolioG
X
Comment by
CoolioG
on Nov 02, 2022 11:47am
RE:Fda loves to waste Canucks time
Bunka bunka bunka......so this is where the dregs of the i-sigh crowd went....shrooms and dope LMAO
(1)
•••
Hammer1
X
Comment by
Hammer1
on Nov 02, 2022 8:50am
RE:Hopefully this week!
The updates move the needle for a day or two..... Then down she goes. Most people watch their investments go up and down and never pull the trigger or the chute for years. I
...more
(36)
•••
WeedKing81
X
Post by
WeedKing81
on Oct 31, 2022 11:33am
Hopefully this week!
Excited to hear the next news updates!
(36)
•••
WeedKing81
X
Post by
WeedKing81
on Oct 31, 2022 11:32am
Hopefully this week!
Excited to here the next news updates!
(8)
•••
RockThunder
X
Comment by
RockThunder
on Oct 31, 2022 10:58am
RE:RE:$RVV - Updated ClinicalTrials.gov
Nothing new, we are just waiting and waiting,,its is just a coin flip and never forget it is and still a penny stock.
(31)
•••
TheTerminator1
X
Comment by
TheTerminator1
on Oct 29, 2022 9:13am
RE:$RVV - Updated ClinicalTrials.gov
What's new???
(27)
•••
cool888
X
Post by
cool888
on Oct 29, 2022 7:49am
$RVV - Updated ClinicalTrials.gov
#Bucillamine https://clinicaltrials.gov/ct2/show/NCT04504734
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
The first public copper company permitted to drill in Argentina’s newly opened Mendoza province
Eshbal Signs Definitive Agreement to Acquire Majority Interest in NYC-Based Dare to Be Different Foods
Allied Critical Metals Confirms Ultra High-Grade Tungsten Zone at Borralha
Pinnacle Extends Gold-Silver Mineralized Horizon to Almost 500 Metres at Historic La Dura Mine
SALT: quietly powering industries, keeping roads safe, and even shaping the global economy